Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Core Scientific Stock (CORZ) Opinions on Analyst Upgrade and Strategic Shift

None

Recent Upgrade Buzz: Core Scientific has been a hot topic on social media lately, with discussions centering on a recent analyst upgrade. Many users are highlighting a positive shift in outlook, pointing to a buy rating and a price target significantly above current levels. The focus is on the company’s potential in high-performance computing and AI infrastructure.

Strategic Moves: Conversations also touch on Core Scientific’s strategic pivot away from traditional Bitcoin mining toward AI and HPC colocation contracts. There’s notable interest in long-term hosting deals projected to bring in substantial revenue, with some expressing optimism about reduced financial strain. The chatter reflects curiosity about how these moves will play out in a volatile market.

Note: This discussion summary was generated from an AI condensation of post data.

Core Scientific Insider Trading Activity

CORZ Insider Trades

Core Scientific insiders have traded $CORZ stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CORZ stock by insiders over the last 6 months:

  • ERIC STANTON WEISS purchased 5,000 shares for an estimated $107,500

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Core Scientific Revenue

CORZ Quarterly Revenue

Core Scientific had revenues of $81.1M in Q3 2025. This is a decrease of -14.95% from the same period in the prior year.

You can track CORZ financials on Quiver Quantitative's CORZ stock page.

Core Scientific Hedge Fund Activity

We have seen 197 institutional investors add shares of Core Scientific stock to their portfolio, and 202 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Core Scientific Analyst Ratings

Wall Street analysts have issued reports on $CORZ in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • BTIG issued a "Buy" rating on 01/06/2026
  • Bernstein issued a "Outperform" rating on 11/03/2025
  • Clear Street issued a "Buy" rating on 10/28/2025
  • HC Wainwright & Co. issued a "Buy" rating on 10/28/2025
  • Cantor Fitzgerald issued a "Overweight" rating on 10/24/2025
  • Roth Capital issued a "Buy" rating on 10/23/2025

To track analyst ratings and price targets for Core Scientific, check out Quiver Quantitative's $CORZ forecast page.

Core Scientific Price Targets

Multiple analysts have issued price targets for $CORZ recently. We have seen 10 analysts offer price targets for $CORZ in the last 6 months, with a median target of $23.75.

Here are some recent targets:

  • Gregory Lewis from BTIG set a target price of $23.0 on 01/06/2026
  • Greg Miller from Citizens set a target price of $30.0 on 12/18/2025
  • Gautam Chhugani from Bernstein set a target price of $24.0 on 11/03/2025
  • Paul Golding from Macquarie set a target price of $34.0 on 10/31/2025
  • Brian Dobson from Clear Street set a target price of $23.0 on 10/28/2025
  • Kevin Dede from HC Wainwright & Co. set a target price of $25.0 on 10/28/2025
  • Brett Knoblauch from Cantor Fitzgerald set a target price of $26.0 on 10/24/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles